These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

158 related items for PubMed ID: 15300188

  • 1. Structure/function studies of an endotoxin-neutralizing peptide derived from bactericidal/permeability-increasing protein.
    Wasiluk KR, Leslie DB, Vietzen PS, Mayo KH, Dunn DL.
    Surgery; 2004 Aug; 136(2):253-60. PubMed ID: 15300188
    [Abstract] [Full Text] [Related]

  • 2. A novel endotoxin antagonist attenuates tumor necrosis factor-alpha secretion.
    Dahlberg PS, Acton RD, Battafarano RJ, Uknis ME, Ratz CA, Johnston JW, Haseman JR, Gray BH, Dunn DL.
    J Surg Res; 1996 Jun; 63(1):44-8. PubMed ID: 8661170
    [Abstract] [Full Text] [Related]

  • 3. A peptide derived from human bactericidal/permeability-increasing protein (BPI) exerts bactericidal activity against Gram-negative bacterial isolates obtained from clinical cases of bovine mastitis.
    Chockalingam A, McKinney CE, Rinaldi M, Zarlenga DS, Bannerman DD.
    Vet Microbiol; 2007 Nov 15; 125(1-2):80-90. PubMed ID: 17560054
    [Abstract] [Full Text] [Related]

  • 4. A synthetic peptide derived from bactericidal/permeability-increasing protein neutralizes endotoxin in vitro and in vivo.
    Jiang Z, Hong Z, Guo W, Xiaoyun G, Gengfa L, Yongning L, Guangxia X.
    Int Immunopharmacol; 2004 Apr 15; 4(4):527-37. PubMed ID: 15099530
    [Abstract] [Full Text] [Related]

  • 5. Probing structure-activity relationships in bactericidal peptide betapep-25.
    Dings RP, Haseman JR, Mayo KH.
    Biochem J; 2008 Aug 15; 414(1):143-50. PubMed ID: 18489259
    [Abstract] [Full Text] [Related]

  • 6. Bactericidal and endotoxin neutralizing activity of a peptide derived from Limulus antilipopolysaccharide factor.
    Weiss CA, Wasiluk KR, Kellogg TA, Dunn DL.
    Surgery; 2000 Aug 15; 128(2):339-44. PubMed ID: 10923014
    [Abstract] [Full Text] [Related]

  • 7. Both N- and C-terminal regions of the bioactive N-terminal fragment of the neutrophil granule bactericidal/permeability-increasing protein are required for stability and function.
    Capodici C, Weiss J.
    J Immunol; 1996 Jun 15; 156(12):4789-96. PubMed ID: 8648126
    [Abstract] [Full Text] [Related]

  • 8. Antimicrobial activity of bovine bactericidal permeability-increasing protein-derived peptides against gram-negative bacteria isolated from the milk of cows with clinical mastitis.
    Chockalingam A, Zarlenga DS, Bannerman DD.
    Am J Vet Res; 2007 Nov 15; 68(11):1151-9. PubMed ID: 17975968
    [Abstract] [Full Text] [Related]

  • 9. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin.
    Marra MN, Wilde CG, Collins MS, Snable JL, Thornton MB, Scott RW.
    J Immunol; 1992 Jan 15; 148(2):532-7. PubMed ID: 1729370
    [Abstract] [Full Text] [Related]

  • 10. The BPI/LBP family of proteins: a structural analysis of conserved regions.
    Beamer LJ, Carroll SF, Eisenberg D.
    Protein Sci; 1998 Apr 15; 7(4):906-14. PubMed ID: 9568897
    [Abstract] [Full Text] [Related]

  • 11. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity.
    Marra MN, Wilde CG, Griffith JE, Snable JL, Scott RW.
    J Immunol; 1990 Jan 15; 144(2):662-6. PubMed ID: 2295804
    [Abstract] [Full Text] [Related]

  • 12. Design of a potent novel endotoxin antagonist.
    Uknis ME, Wasiluk KR, Acton RD, Klaerner HG, Dahlberg PS, Ilyina EE, Haseman JR, Gray BH, Mayo KH, Dunn DL.
    Surgery; 1997 Aug 15; 122(2):380-5. PubMed ID: 9288144
    [Abstract] [Full Text] [Related]

  • 13. Peptide derivatives of three distinct lipopolysaccharide binding proteins inhibit lipopolysaccharide-induced tumor necrosis factor-alpha secretion in vitro.
    Battafaraono RJ, Dahlberg PS, Ratz CA, Johnston JW, Gray BH, Haseman JR, Mayo KH, Dunn DL.
    Surgery; 1995 Aug 15; 118(2):318-24. PubMed ID: 7638748
    [Abstract] [Full Text] [Related]

  • 14. [A study on bactericidal/permeability increasing protein (BPI) as a natural inhibitor of endotoxin].
    Zhou H.
    Zhonghua Shao Shang Za Zhi; 2001 Apr 15; 17(2):102-4. PubMed ID: 11876922
    [Abstract] [Full Text] [Related]

  • 15. [The study on the role of modeling peptides derived from bactericidal/permeability increasing protein on the endotoxin neutralization].
    Zheng J, Zhou H, Lu Y, Xiao G.
    Zhonghua Shao Shang Za Zhi; 2002 Apr 15; 18(2):95-8. PubMed ID: 12515655
    [Abstract] [Full Text] [Related]

  • 16. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins.
    Levy O, Ooi CE, Elsbach P, Doerfler ME, Lehrer RI, Weiss J.
    J Immunol; 1995 May 15; 154(10):5403-10. PubMed ID: 7730641
    [Abstract] [Full Text] [Related]

  • 17. Designed beta-sheet-forming peptide 33mers with potent human bactericidal/permeability increasing protein-like bactericidal and endotoxin neutralizing activities.
    Mayo KH, Haseman J, Ilyina E, Gray B.
    Biochim Biophys Acta; 1998 Sep 16; 1425(1):81-92. PubMed ID: 9813253
    [Abstract] [Full Text] [Related]

  • 18. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein.
    Bülow E, Gullberg U, Olsson I.
    J Leukoc Biol; 2000 Nov 16; 68(5):669-78. PubMed ID: 11073106
    [Abstract] [Full Text] [Related]

  • 19. Parameters involved in antimicrobial and endotoxin detoxification activities of antimicrobial peptides.
    Rosenfeld Y, Sahl HG, Shai Y.
    Biochemistry; 2008 Jun 17; 47(24):6468-78. PubMed ID: 18498177
    [Abstract] [Full Text] [Related]

  • 20. rBPI(10-193) is secreted by CHO cells and retains the activity of rBPI21.
    Horwitz AH, Ammons WS, Bauer RJ, Dedrick R, Nadell R, Williams RE, Liu PS.
    J Endotoxin Res; 2004 Jun 17; 10(2):97-106. PubMed ID: 15120000
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.